Home » COVALON, MEDLINE APPLY FOR FDA APPROVAL FOR COVALON'S SILVER ION ANTIMICROBIAL COATING
COVALON, MEDLINE APPLY FOR FDA APPROVAL FOR COVALON'S SILVER ION ANTIMICROBIAL COATING
Covalon Technologies Ltd. (Covalon) (TSX VENTURE:COV) is extremely pleased to announce that Medline Industries Inc. USA has made a 510(k) application for FDA approval of Covalon's antimicrobial silver coating for medical devices. Covalon CEO, Dr. Frank DiCosmo said: "The FDA application is an extremely important milestone in the commercialization of Covalon's covalent coating technology for medical devices. A silver ion releasing coating is only one example of such a device. The Covalon coating allows for site specific delivery of various therapeutics used in many combination medical devices."
CCNMatthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&actionFor=552327)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May